Testing effectiveness (Phase 2)UnknownNCT04548271
What this trial is testing
Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 25